Zhimin Zeng
No.1 Minde Street
Nanchang, 330000, China
Nanchang, 330000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 16, 2025
Efficacy and safety of concurrent chemoradiotherapy following neoadjuvant chemoimmunotherapy in patients with stage III NSCLC who experienced neoadjuvant failure: A real-world study.
Journal: Oncology letters
Published: October 04, 2025
Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy-Induced Cardiac Fibrosis Based on Single-Cell Transcriptomic Analysis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 01, 2025
Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 18, 2025
Comparative efficacy of positive airway pressure-based combination therapy in comorbid insomnia and sleep apnea: A systematic review and network meta-analysis.
Journal: Sleep medicine reviews
Published: August 17, 2025
Identification of features and differences in PD-1 inhibitor-associated myocarditis and acute myocardial infarction using proteomic analysis: a clinical and preclinical study.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: August 14, 2025
Integrated multi-omics reveals glycolytic gene signatures of lung adenocarcinoma brain metastasis and the impact of Rac2 lactylation on immunosuppressive microenvironment.
Journal: Journal of translational medicine
Published: June 29, 2025
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).
Journal: Frontiers in immunology
Published: May 23, 2025
Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations.
Journal: Translational lung cancer research
Published: March 08, 2025
Acetylation of FABP3 alleviates radioimmunotherapy-induced cardiomyocyte senescence by modulating long-chain polyunsaturated fatty acid metabolism.
Journal: International immunopharmacology
Published: March 02, 2025
Intrathecal Pemetrexed Administration and Myelosuppression in Patients with Leptomeningeal Metastases from Lung Adenocarcinoma: A Retrospective Study.
Journal: Oncology research
Published: February 09, 2025
Comparison of clinical outcomes in patients with advanced pulmonary sarcomatoid carcinoma treated with immunotherapy-based regimens or chemotherapy: A study based on the SEER database and multicentric real-world settings.
Journal: Journal of cancer research and therapeutics
Published: March 09, 2024
Last Updated: 09/26/2026